American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement

Alan Garber; Martin Abrahamson; Joshua Barzilay; Lawrence Blonde; Zachary Bloomgarden; Michael Bush; Samuel Dagogo-Jack; Michael Davidson; Daniel Einhorn; W. Garvey; George Grunberger; Yehuda Handelsman; Irl Hirsch; Paul Jellinger; Janet McGill; Jeffrey Mechanick; Paul Rosenblit; Guillermo Umpierrez; Michael Devidson

doi:10.4158/EP13176.CSUPPL

American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement

Alan Garber, Martin Abrahamson, Joshua Barzilay, Lawrence Blonde, Zachary Bloomgarden, Michael Bush, Samuel Dagogo-Jack, Michael Davidson, Daniel Einhorn, W. Garvey, George Grunberger, Yehuda Handelsman, Irl Hirsch, Paul Jellinger, Janet McGill, Jeffrey Mechanick, Paul Rosenblit, Guillermo Umpierrez, Michael Devidson

Research output: Contribution to journal › Article › peer-review

106 Scopus citations

Abstract

This new algorithm for the comprehensive management of persons with type 2 diabetes mellitus (T2DM) has been developed to provide clinicians with a practical guide that considers the whole patient, the spectrum of risks and complications for the patient, and evidence-based approaches to treatment. In addition to advocating for glycemic control so as to reduce microvascular complications, this document focuses on obesity and prediabetes as the underlying risk factors for diabetes and associated macrovascular complications. It is now clear that the progressive beta-cell defect that drives the deterioration of metabolic control over time begins early and may be present before the diagnosis of diabetes (1). This document is organized into discrete sections that address the following topics: obesity, prediabetes, management of hyperglycemia through lifestyle modifications, pharmacotherapy and insulin, management of hypertension, management of hyperlipidemia, and other risk-reduction strategies.

Original language	English
Pages (from-to)	1-48
Number of pages	48
Journal	Endocrine Practice
Volume	19
Issue number	SUPPL. 2
DOIs	https://doi.org/10.4158/EP13176.CSUPPL
State	Published - 1 May 2013

Access to Document

10.4158/EP13176.CSUPPL

Cite this

Garber, A., Abrahamson, M., Barzilay, J., Blonde, L., Bloomgarden, Z., Bush, M., Dagogo-Jack, S., Davidson, M., Einhorn, D., Garvey, W., Grunberger, G., Handelsman, Y., Hirsch, I., Jellinger, P., McGill, J., Mechanick, J., Rosenblit, P., Umpierrez, G., & Devidson, M. (2013). American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement. Endocrine Practice, 19(SUPPL. 2), 1-48. https://doi.org/10.4158/EP13176.CSUPPL

@article{a568a4505c874f22a99ad3eb3513be5a,

title = "American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement",

abstract = "This new algorithm for the comprehensive management of persons with type 2 diabetes mellitus (T2DM) has been developed to provide clinicians with a practical guide that considers the whole patient, the spectrum of risks and complications for the patient, and evidence-based approaches to treatment. In addition to advocating for glycemic control so as to reduce microvascular complications, this document focuses on obesity and prediabetes as the underlying risk factors for diabetes and associated macrovascular complications. It is now clear that the progressive beta-cell defect that drives the deterioration of metabolic control over time begins early and may be present before the diagnosis of diabetes (1). This document is organized into discrete sections that address the following topics: obesity, prediabetes, management of hyperglycemia through lifestyle modifications, pharmacotherapy and insulin, management of hypertension, management of hyperlipidemia, and other risk-reduction strategies.",

author = "Alan Garber and Martin Abrahamson and Joshua Barzilay and Lawrence Blonde and Zachary Bloomgarden and Michael Bush and Samuel Dagogo-Jack and Michael Davidson and Daniel Einhorn and W. Garvey and George Grunberger and Yehuda Handelsman and Irl Hirsch and Paul Jellinger and Janet McGill and Jeffrey Mechanick and Paul Rosenblit and Guillermo Umpierrez and Michael Devidson",

year = "2013",

month = may,

day = "1",

doi = "10.4158/EP13176.CSUPPL",

language = "English",

volume = "19",

pages = "1--48",

journal = "Endocrine Practice",

issn = "1530-891X",

publisher = "Elsevier B.V.",

number = "SUPPL. 2",

}

Garber, A, Abrahamson, M, Barzilay, J, Blonde, L, Bloomgarden, Z, Bush, M, Dagogo-Jack, S, Davidson, M, Einhorn, D, Garvey, W, Grunberger, G, Handelsman, Y, Hirsch, I, Jellinger, P, McGill, J, Mechanick, J, Rosenblit, P, Umpierrez, G & Devidson, M 2013, 'American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement', Endocrine Practice, vol. 19, no. SUPPL. 2, pp. 1-48. https://doi.org/10.4158/EP13176.CSUPPL

TY - JOUR

T1 - American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement

AU - Garber, Alan

AU - Abrahamson, Martin

AU - Barzilay, Joshua

AU - Blonde, Lawrence

AU - Bloomgarden, Zachary

AU - Bush, Michael

AU - Dagogo-Jack, Samuel

AU - Davidson, Michael

AU - Einhorn, Daniel

AU - Garvey, W.

AU - Grunberger, George

AU - Handelsman, Yehuda

AU - Hirsch, Irl

AU - Jellinger, Paul

AU - McGill, Janet

AU - Mechanick, Jeffrey

AU - Rosenblit, Paul

AU - Umpierrez, Guillermo

AU - Devidson, Michael

PY - 2013/5/1

Y1 - 2013/5/1

N2 - This new algorithm for the comprehensive management of persons with type 2 diabetes mellitus (T2DM) has been developed to provide clinicians with a practical guide that considers the whole patient, the spectrum of risks and complications for the patient, and evidence-based approaches to treatment. In addition to advocating for glycemic control so as to reduce microvascular complications, this document focuses on obesity and prediabetes as the underlying risk factors for diabetes and associated macrovascular complications. It is now clear that the progressive beta-cell defect that drives the deterioration of metabolic control over time begins early and may be present before the diagnosis of diabetes (1). This document is organized into discrete sections that address the following topics: obesity, prediabetes, management of hyperglycemia through lifestyle modifications, pharmacotherapy and insulin, management of hypertension, management of hyperlipidemia, and other risk-reduction strategies.

AB - This new algorithm for the comprehensive management of persons with type 2 diabetes mellitus (T2DM) has been developed to provide clinicians with a practical guide that considers the whole patient, the spectrum of risks and complications for the patient, and evidence-based approaches to treatment. In addition to advocating for glycemic control so as to reduce microvascular complications, this document focuses on obesity and prediabetes as the underlying risk factors for diabetes and associated macrovascular complications. It is now clear that the progressive beta-cell defect that drives the deterioration of metabolic control over time begins early and may be present before the diagnosis of diabetes (1). This document is organized into discrete sections that address the following topics: obesity, prediabetes, management of hyperglycemia through lifestyle modifications, pharmacotherapy and insulin, management of hypertension, management of hyperlipidemia, and other risk-reduction strategies.

UR - http://www.scopus.com/inward/record.url?scp=84879944944&partnerID=8YFLogxK

U2 - 10.4158/EP13176.CSUPPL

DO - 10.4158/EP13176.CSUPPL

M3 - Article

AN - SCOPUS:84879944944

SN - 1530-891X

VL - 19

SP - 1

EP - 48

JO - Endocrine Practice

JF - Endocrine Practice

IS - SUPPL. 2

ER -

American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement

Abstract

Access to Document

Fingerprint

Cite this